BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang SC, Chan GC, Lai KN. Recent advances in managing and understanding diabetic nephropathy. F1000Res. 2016;5:pii: F1000 Faculty Rev-1044. [PMID: 27303648 DOI: 10.12688/f1000research.7693.1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Cha AS, Chen Y, Fazioli K, Rivara MB, Devine EB. Microvascular Benefits of New Antidiabetic Agents: A Systematic Review and Network Meta-Analysis of Kidney Outcomes. J Clin Endocrinol Metab 2021;106:1225-34. [PMID: 33248440 DOI: 10.1210/clinem/dgaa894] [Reference Citation Analysis]
2 Emoto N, Okajima F, Sugihara H, Goto R. A socioeconomic and behavioral survey of patients with difficult-to-control type 2 diabetes mellitus reveals an association between diabetic retinopathy and educational attainment. Patient Prefer Adherence 2016;10:2151-62. [PMID: 27822016 DOI: 10.2147/PPA.S116198] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
3 Zhou H, Li W, Sun L, Li W, Liu Q. A rapid LC-MS/MS method for simultaneous determination of berberine and irbesartan in rat plasma: Application to the drug-drug pharmacokinetic interaction study after oral administration in rats. Biomed Chromatogr 2021;35:e5144. [PMID: 33880775 DOI: 10.1002/bmc.5144] [Reference Citation Analysis]
4 Tang S, Gao C, Long Y, Huang W, Chen J, Fan F, Jiang C, Xu Y. Maresin 1 Mitigates High Glucose-Induced Mouse Glomerular Mesangial Cell Injury by Inhibiting Inflammation and Fibrosis. Mediators Inflamm 2017;2017:2438247. [PMID: 28182085 DOI: 10.1155/2017/2438247] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
5 Hsu WH, Hsiao PJ, Lin PC, Chen SC, Lee MY, Shin SJ. Effect of metformin on kidney function in patients with type 2 diabetes mellitus and moderate chronic kidney disease. Oncotarget 2018;9:5416-23. [PMID: 29435189 DOI: 10.18632/oncotarget.23387] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
6 Goenka L, Padmanaban R, George M. The Ascent of Mineralocorticoid Receptor Antagonists in Diabetic Nephropathy. Curr Clin Pharmacol 2019;14:78-83. [PMID: 30444201 DOI: 10.2174/1574884713666181116100946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Lengnan X, Ban Z, Haitao W, Lili L, Aiqun C, Huan W, Ping Z, Yonghui M. Tripterygium wilfordii Hook F Treatment for Stage IV Diabetic Nephropathy: Protocol for a Prospective, Randomized Controlled Trial. Biomed Res Int 2020;2020:9181037. [PMID: 32596393 DOI: 10.1155/2020/9181037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
8 Xu L, Sinclair AJ, Faiza M, Li D, Han X, Yin H, Wang Y. Furan fatty acids - Beneficial or harmful to health? Prog Lipid Res 2017;68:119-37. [PMID: 29051014 DOI: 10.1016/j.plipres.2017.10.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
9 Lawson CA, Seidu S, Zaccardi F, McCann G, Kadam UT, Davies MJ, Lam CS, Heerspink HL, Khunti K. Outcome trends in people with heart failure, type 2 diabetes mellitus and chronic kidney disease in the UK over twenty years. EClinicalMedicine 2021;32:100739. [PMID: 33688855 DOI: 10.1016/j.eclinm.2021.100739] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhang H, Zhao T, Li Z, Yan M, Zhao H, Zhu B, Li P. Transcriptional Profile of Kidney from Type 2 Diabetic db/db Mice. J Diabetes Res 2017;2017:8391253. [PMID: 28232950 DOI: 10.1155/2017/8391253] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
11 Niazpour F, Bahiraee A, Esfahani EN, Abdollahi M, Bandarian F, Razi F. Comparison of glomerular filtration rate estimation using Jaffé and enzymatic creatinine assays in diabetic patients. J Diabetes Metab Disord 2019;18:551-6. [PMID: 31890681 DOI: 10.1007/s40200-019-00462-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Demircan S, Onalan E, Kuloğlu T, Aydın S, Yalçın MH, Gözel N, Dönder E. Effects of vitamin D on apoptosis and betatrophin in the kidney tissue of experimental diabetic rats. Acta Biomed 2020;91:e2020089. [PMID: 33525266 DOI: 10.23750/abm.v91i4.8944] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Voulgaris A, Marrone O, Bonsignore MR, Steiropoulos P. Chronic kidney disease in patients with obstructive sleep apnea. A narrative review. Sleep Med Rev 2019;47:74-89. [PMID: 31376590 DOI: 10.1016/j.smrv.2019.07.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
14 Lovrenčić MV, Biljak VR, Blaslov K, Božičević S, Duvnjak LS. Impact of creatinine methodology on glomerular filtration rate estimation in diabetes. World J Diabetes 2017; 8(5): 222-229 [PMID: 28572883 DOI: 10.4239/wjd.v8.i5.222] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
15 Ilyas Z, Chaiban JT, Krikorian A. Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy. Rev Endocr Metab Disord 2017;18:21-8. [PMID: 28289965 DOI: 10.1007/s11154-017-9422-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]